Gliter 15 mg

Manufacturer: Mass/Ph. Health
Generic: Pioglitazone 15 mg
Guarantee: 100% Genuine Product
Delivery: 24 Hours
Availability: In stock
75.60

Risk Factors:

Contraindications: Hypersensitivity to pioglitazone. NYHA class III/IV HF (at initiation of therapy).Pregnancy/Lactation: Unknown if drug crosses placenta or is distributed in breast milk. Not recommended in pregnant or breastfeeding women. Children: Safety and efficacy not esTabletlished. Elderly: No age-related precautions noted.


Indications:

Adjunct to diet and exercise to lower serum glucose in those with type 2
diabetes. Used as monotherapy or combination therapy.


Adverse Effects:

Frequent (13%?9%): Headache upper respiratory tract infection. Occasional
(6%?5%): Sinusitis myalgia pharyngitis aggravated diabetes edema.
Adverse effects/toxic reactions
Hepatotoxicity occurs rarely. May cause/worsen macular edema. Increased risk
of HF. May increase risk of fractures. Pts with ischemic heart disease are at high
risk of MI.


Don’t Use:

Hepatic impairment anemia pts with edema;
avoid in pts with bladder cancer. For premenopausal anovulatory women may
result in ovulation resumption increased risk of pregnancy. NYHA class I/II HF.

Alternatives for Pioglitazone 15 mg

Glitlite 15 mgGlitz 67.50
Diglyta 15 mgZafa 83.70
Diacto 15 mgCCL 88.20
Ligazo 15 mgPfizer 103.01
Piozer 15 mgHilton 115.00
Piozer 15 mgHilton 207.00
Pion t 15 mgFerroza 315.00
All copyright reserved by GENMED
Technology Partners: Smuftech